EOD Primary Tumor

Notes

**Note:** In case of multifocal noninvasive tumors (code 000) and in situ tumors (code 050), code 050.

Code	Description	SS2018 T
000	Non-invasive papillary carcinoma	IS
050	Carcinoma in situ involving (WITHOUT stromal invasion) - Periurethral or prostatic ducts - Prostatic urethra	IS
100	Subepithelial connective tissue (lamina propria, submucosa) invaded Localized, NOS	L
300	Prostate (prostatic stroma) Prostatic ducts	RE
400	Bladder neck Periprostatic fat (beyond prostate capsule)	RE
700	Adjacent organ(s), NOS Bladder wall Extraprostatic invasion bladder wall Rectal wall Further contiguous extension	D
800	No evidence of primary tumor	U
999	Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record Death Certificate Only	U

(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Hansel, D.E., Reuter, V.E., McKiernan, J.M., et al. **Urethra**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 767-776